Meiji Yasuda Life Insurance Co decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,533 shares of the medical equipment provider’s stock after selling 396 shares during the period. Meiji Yasuda Life Insurance Co’s holdings in Intuitive Surgical were worth $1,445,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc lifted its position in Intuitive Surgical by 0.4% during the third quarter. Vanguard Group Inc now owns 8,313,421 shares of the medical equipment provider’s stock valued at $4,771,903,000 after purchasing an additional 29,260 shares during the last quarter. Advisors Asset Management Inc. lifted its position in Intuitive Surgical by 17.9% during the fourth quarter. Advisors Asset Management Inc. now owns 14,034 shares of the medical equipment provider’s stock valued at $6,721,000 after purchasing an additional 2,129 shares during the last quarter. Capital Investment Advisory Services LLC bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $144,000. Daiwa Securities Group Inc. lifted its position in Intuitive Surgical by 1.8% during the fourth quarter. Daiwa Securities Group Inc. now owns 4,540 shares of the medical equipment provider’s stock valued at $2,174,000 after purchasing an additional 79 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in Intuitive Surgical by 39.9% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 7,409 shares of the medical equipment provider’s stock valued at $3,548,000 after purchasing an additional 2,114 shares during the last quarter. Institutional investors and hedge funds own 85.53% of the company’s stock.
Shares of ISRG stock traded down $2.77 during trading hours on Wednesday, hitting $503.79. 14,063 shares of the company’s stock were exchanged, compared to its average volume of 783,795. The company has a market capitalization of $57.89 billion, a PE ratio of 53.02, a price-to-earnings-growth ratio of 4.35 and a beta of 1.06. Intuitive Surgical, Inc. has a 12-month low of $430.24 and a 12-month high of $589.32.
In related news, VP Jamie Samath sold 260 shares of Intuitive Surgical stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $500.00, for a total value of $130,000.00. Following the transaction, the vice president now directly owns 278 shares of the company’s stock, valued at $139,000. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Curet Myriam sold 2,200 shares of Intuitive Surgical stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $493.26, for a total transaction of $1,085,172.00. Following the completion of the transaction, the executive vice president now directly owns 3,101 shares in the company, valued at $1,529,599.26. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,621 shares of company stock worth $13,828,454. 1.70% of the stock is owned by insiders.
Several brokerages have issued reports on ISRG. BidaskClub upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday. Zacks Investment Research raised shares of Intuitive Surgical from a “sell” rating to a “hold” rating in a research note on Wednesday, April 17th. BTIG Research reissued a “hold” rating on shares of Intuitive Surgical in a research note on Sunday, April 21st. Piper Jaffray Companies reissued an “overweight” rating and set a $610.00 price target on shares of Intuitive Surgical in a research note on Thursday, April 18th. Finally, Canaccord Genuity reissued a “buy” rating and set a $575.00 price target (down from $610.00) on shares of Intuitive Surgical in a research note on Monday, April 22nd. Two analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $576.82.
WARNING: This story was first posted by Week Herald and is the sole property of of Week Herald. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://weekherald.com/2019/06/12/meiji-yasuda-life-insurance-co-sells-396-shares-of-intuitive-surgical-inc-nasdaqisrg.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Article: What are convertible shares?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.